Results 111 to 120 of about 3,499 (203)

Response to Behrens and Edwards: Atovaquone-proguanil exposure in pregnancy should not be condemned from current evidence. [PDF]

Travel Med Infect Dis, 2020
Gutman JR, Tan KR.
europepmc   +1 more source

N Engl J Med [PDF]

BackgroundAvailable data on the characteristics of patients with Ebola virus disease (EVD) and clinical management of EVD in settings outside West Africa, as well as the complications observed in those patients, are limited.MethodsWe reviewed available ...

core  

Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis [PDF]

, 2013

core   +1 more source

Atovaquone-proguanil exposure in pregnancy and risk for adverse fetal and infant outcomes: A retrospective analysis. [PDF]

Travel Med Infect Dis, 2019
Gutman JR, Hall C, Khodr ZG, Bukowinski AT, Gumbs GR, Conlin AMS, Wells NY, Tan KR.   +7 more
europepmc   +1 more source

The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review. [PDF]

Travel Med Infect Dis, 2019
Andrejko KL, Mayer RC, Kovacs S, Slutsker E, Bartlett E, Tan KR, Gutman JR.   +6 more
europepmc   +1 more source

A randomized, open-label two-period crossover pilot study to evaluate the relative bioavailability in the fed state of atovaquone-proguanil (Atoguanil™) versus atovaquone-proguanil hydrochloride (Malarone®) in healthy adult participants. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Kuemmerle A, Gossen D, Marx MW, Lorch U, Szramowska M, Kumar A, Singh D, Singh S, Ramachandruni H, Thankachen B, Kore S, Gaaloul ME, Borghini-Fuhrer I, Chalon S.   +13 more
europepmc   +1 more source

Atovaquone-Proguanil in Combination With Artesunate to Treat Multidrug-Resistant P. falciparum Malaria in Cambodia: An Open-Label Randomized Trial. [PDF]

Open Forum Infect Dis, 2019
Wojnarski M, Lon C, Vanachayangkul P, Gosi P, Sok S, Rachmat A, Harrison D, Berjohn CM, Spring M, Chaoratanakawee S, Ittiverakul M, Buathong N, Chann S, Wongarunkochakorn S, Waltmann A, Kuntawunginn W, Fukuda MM, Burkly H, Heang V, Heng TK, Kong N, Boonchan T, Chum B, Smith P, Vaughn A, Prom S, Lin J, Lek D, Saunders D.   +28 more
europepmc   +1 more source

Superior protection in a relapsing Plasmodium cynomolgi rhesus macaque model by a chemoprophylaxis with sporozoite immunization regimen with atovaquone-proguanil followed by primaquine. [PDF]

Malar J
Yongvanitchit K, Kum-Arb U, Limsalakpetch A, Im-Erbsin R, Ubalee R, Spring MD, Vesely BA, Waters N, Pichyangkul S.   +8 more
europepmc   +1 more source

Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis. [PDF]

J Antimicrob Chemother, 2018
Staines HM, Burrow R, Teo BH, Chis Ster I, Kremsner PG, Krishna S.   +5 more
europepmc   +1 more source

Introducing GSA: surface antigens of P-falciparum gametocyte-infected erythrocytes [PDF]

, 2008
Drakeley, CJ, Fivelman, Q, Saeed, M, Sutherland, C, Targett, GAT   +4 more
core   +1 more source